Stock peptide
-
Human CMV pp65 (495-503)
Human CMV pp65 (495-503)
Full Name：Human CMV pp65 (495-503)
Sequence：Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val
-
β-Amyloid (1-42),human
β-Amyloid (1-42),human
Full Name：β-Amyloid (1-42),human
Cas No：107761-42-2
Sequence：Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
-
Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human
Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human
Full Name：Glucagon - Like Peptide 1, (GLP-1/GLP1) amide, human
Sequence：His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2
This class of drugs is used for the treatment of type 2 diabetes. One of their advantages over older insulin secretagogues, such as sulfonylureas or meglitinides, is that they have a lower risk of causing hypoglycemia. -
MOG35-55
MOG35-55
Full Name：MOG35-55
Cas No：149635-73-4
Sequence：Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys
-
ACTH (1-10), human
ACTH (1-10), human
Full Name：ACTH (1-10), human
Cas No： 2791-05-1
Sequence：Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly
-
TAT peptide
TAT peptide
Full Name：TAT peptide
Sequence：Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Pro-Gln
-
Triple Flag
Triple Flag
Full Name：Triple Flag
Sequence：Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys
-
3Flag
3Flag
Full Name：3Flag
Sequence：Met-Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-Leu
-
3xFLAG
3xFLAG
Full Name：3xFLAG
Sequence：Met-Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys
-
